Reshma Kewalramani, EVP and CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 509 shares at $199.00 ($101K) on 2019-11-08, disclosed to the SEC on 2019-11-13.
Open-market sale of $101k VRTX by EVP and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |